In his role as chief technology officer at Myriad Genetics, Kevin Haas, PhD, leads the development of the precision medicine platform, including the company’s patient/provider digital experience and advanced genomics, harnessing genetic data, and powering breakthrough products to serve millions of customers. He has expertise in AI and machine learning applied to biophysical systems and genetics. 

Haas joined Myriad in May 2013, serving previously as senior vice president of technology and senior vice president of engineering at Myriad, as well as vice president of bioinformatics at Myriad Women's Health. He received a BS from University of Wisconsin-Madison and a PhD in chemical engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluoresce. He has co-authored 16 peer reviewed publications and nine patent applications.